Moisture is both friend and foe in chronic wound care. When exudate overwhelms the dressing or pools at the edges, periwound skin overhydrates, turns white and boggy, and breaks down—classic maceration. This guide shows you how to prevent maceration in high-exudate wounds using pragmatic, evidence‑informed steps for three everyday scenarios: venous leg ulcers under compression, diabetic foot ulcers with offloading, and sacrum/heel pressure injuries.
Most recommendations below synthesize category‑level evidence and best‑practice statements published 2021–2026. Direct head‑to‑head randomized trials in VLUs/DFUs/PIs comparing superabsorbent polymer (SAP) dressings to standard silicone foams on leakage or maceration are limited; where we extrapolate, we say so and prioritize clinical signs over fixed maximum wear times.
Quick assessment to prevent maceration in high-exudate wounds
Start by naming what you see and why it’s happening. High exudate often tracks with inflammation, bioburden, and edema. Look for visible pooling, frequent strike‑through, expanding periwound whitening, and odor unrelated to topicals. In VLUs, uncontrolled edema drives output until compression is optimized. In DFUs, pressure and shear under devices create moisture traps. Sacrum/heel pressure injuries add difficult contours and prolonged loading.
Practical rule of thumb: if a modern silicone foam shows strike‑through within 24–48 hours on two consecutive changes—or if periwound maceration remains >5–10 mm wide—escalate your dressing system for higher retention and better edge protection.
SAP vs standard silicone foam: what changes at the bedside
Superabsorbent polymer dressings are engineered to wick fluid vertically and lock it in a high‑retention core, minimizing backflow toward the periwound. Standard silicone foams manage moderate exudate well and offer atraumatic removal, but they can reach saturation quickly in heavy output or under sustained pressure (for example, beneath compression wraps).
What the evidence supports today:
In vitro work with a silicone SAP dressing demonstrated strong fluid sequestration and modulation of selected pro‑inflammatory proteins—mechanisms that align with maceration risk reduction when exudate is heavy. See the 2025 laboratory evaluation in Wounds International, summarized as an in‑vitro capability rather than a clinical outcome claim, in the article titled In vitro evaluation of the capability of a silicone superabsorbent polymer (SAP) dressing to modulate pro-inflammatory cytokines (2025) at Wounds International.
A 2024 systematic review reported that superabsorbent dressings often achieved longer wear intervals and favorable wound progression compared with some foam comparators in chronic wounds, though leakage and maceration were not consistent primary endpoints. See the systematic review of superabsorbent dressings (2024) hosted on PMC.
Limitations to keep front‑of‑mind: High‑quality randomized comparisons in VLUs/DFUs/PIs with leakage or maceration as primary outcomes are sparse. Use category logic plus direct observation to decide when to escalate from foam to SAP.
A stepwise algorithm to prevent maceration in high-exudate wounds
Assess drivers and risk: check edema, signs of inflammation/infection, device pressure/shear, and anatomical contours. Document exudate level (moderate/high/copious), strike‑through timing, and periwound condition (width of whitening/bogginess in mm).
Select your stack: for heavy or copious exudate, consider a vertical‑wicking sequence—gelling fiber primary for viscous fluid, a gentle silicone interface for atraumatic removal, and a high‑retention superabsorbent secondary. For moderate exudate without early strike‑through, a modern silicone foam may suffice.
Protect the edges: cleanse with a pH‑balanced cleanser, pat dry, then apply a no‑sting liquid barrier film (or appropriate cyanoacrylate/silicone‑based barrier) around the wound and under anticipated adhesive borders. Allow full drying/cure per IFU before dressing placement. These steps align with internationally recognized MASD best‑practice recommendations; see the Prevention and management of moisture-associated skin damage best practice statement from 2025 at Wounds International.
Secure for the setting: under compression, ensure dressings are trimmed to avoid ridging and placed to preserve gradient; with offloading devices, avoid occluding breathable backings and manage liners to prevent moisture traps; on sacrum/heel, contour and seal carefully to prevent lateral spread.
Define change triggers: change at first signs of strike‑through, border saturation, widening maceration rim (>5–10 mm), new edge pain, or odor increase not tied to topicals—do not wait for maximum IFU days.
Document and audit: capture leakage events/week, unplanned changes, maceration rim width, wrap/device integrity notes, and patient comfort. Reassess after 2–4 weeks; if indicators don’t improve, escalate product category or address underlying drivers (e.g., optimize compression).
VLU under compression: leak‑proofing the wrap
In venous disease, compression reduces edema and, over time, exudate—but only if the wrap stays dry and intact. To prevent maceration in high‑exudate wounds here, design a stack that resists saturation while preserving compression integrity.
Compose the stack in a way that makes the compression do its job without creating moisture channels. Place a silicone contact layer over the wound bed for gentle removal on fragile tissue. Add a gelling fiber primary if exudate is viscous, then use a superabsorbent secondary sized so the absorbent area sits 1–2 cm inside the wrap edges to prevent ridging. Apply compression with even tension. After ambulation, inspect posterior calf and ankle flexion points for dampness; if present, schedule an earlier change and adjust dressing size or retention capacity.
From an evidence perspective, engineering and bench reviews of foam fluid handling highlight that wear time is driven by exudate burden, pressure, and contour—not just IFU maximums. For a deeper discussion of foam fluid‑handling determinants (2024), see the review on PMC. Track unplanned changes and minutes per event; services frequently observe fewer unplanned changes after escalating appropriate patients to a higher‑retention stack, but quantify locally.
DFU with offloading: moisture control inside devices
Offloading boots and orthotics can trap heat and moisture. Even with a breathable dressing, maceration risk climbs if liners aren’t managed. Set a schedule for changing/airing boot liners or socks; ensure the device fit doesn’t compress dressing borders excessively. If pooling is observed, use a gelling fiber primary to channel exudate upward and pair it with a high‑retention secondary. Check high‑pressure contact points within 24–48 hours for early edge lift or whitening. As inflammation settles and load redistributes, exudate often decreases; reassess the need for a superabsorbent secondary and consider stepping back to foam when strike‑through intervals lengthen.
Sacrum and heel pressure injuries: contour‑aware protection
Curved, mobile surfaces favor lateral spread and edge pooling. Your aim is to create a sealed, breathable micro‑environment without shearing the periwound. After barrier film fully dries, contour the silicone interface carefully, avoiding tension. Choose a superabsorbent secondary with a breathable backing and secure edges without stretching. For longer wear, arrange a check at 24–48 hours (in person or via home‑health touchpoint) to catch early whitening or edge lift. If maceration widens or odor rises, change early and reassess your stack or sizing.
Realistic wear‑time matrix
Change intervals are governed by clinical signs first, IFU maximums second. The following ranges reflect category‑level evidence and common practice in heavy exudate; always shorten intervals when strike‑through or periwound compromise appears. A 2024 systematic review suggested that superabsorbents often enable longer intervals than some foams in chronic wounds, but individual results vary; see the systematic review (2024) on PMC.
Setting: heavy exudate | Typical interval with SAP stack | Typical interval with silicone foam |
|---|---|---|
VLU under compression | 48–96 hours planned; sooner if channeling or damp wrap | 48–120 hours when output controlled; 24–72 hours if frequent strike‑through |
DFU with offloading | 48–96 hours; check device liners at 24–48 hours | 48–96 hours with vigilant edge checks |
Sacrum/heel pressure injuries | 48–96 hours; contouring may shorten interval | 48–96 hours; earlier if border lift or widening maceration |
Monitoring MASD and MARSI during longer wear
Moisture‑associated skin damage (MASD) and medical adhesive–related skin injury (MARSI) are preventable with a consistent routine. International best‑practice statements emphasize cleanse–protect–absorb, paired with gentle adhesive handling. See the Best Practice Recommendations for MASD (2025) at Wounds International and a practical MASD overview (2022) from American Nurse. The IWII 2022 consensus also frames moisture balance within overall wound bed preparation; reference the 2022 document at Wounds International.
Checklist for longer wear monitoring:
Periwound and border checks at each change (and at 24–48 hours during longer wear when feasible): look for whitening, bogginess, widening maceration rim (>5–10 mm), new pain, or edge lift.
Adhesive safety: prefer soft silicone adhesives on at‑risk skin; remove “low and slow” while supporting skin; avoid alcohol‑based products directly under adhesives on fragile skin.
Change now if: strike‑through or border saturation appears; odor increases (not explained by topicals); the maceration rim widens; the wrap/device becomes damp or unstable.
Re‑apply barriers per IFU at each change; allow full drying/cure before re‑dressing.
What to document and how to evaluate success
Strong documentation turns bedside impressions into service‑level learning. Record leakage (strike‑through) events per week and unplanned changes. Note average nursing time per unplanned change (minutes) and supply consumption per patient per week. Track periwound maceration rim width (in mm) and trend over 2–4 weeks. Include wrap integrity events (for VLU) and device‑related moisture issues (for DFU). Capture patient comfort and ease of removal; silicone interfaces often help reduce MARSI risk and pain on removal.
If leakage and unplanned changes fall while maceration stabilizes or recedes, your regimen is working. If indicators plateau or worsen, revisit underlying drivers (edema control, bioburden, device fit) and escalate absorption/retention capacity or revise the stack.
Appendix: practical example and resources
The following neutral example illustrates how a vertical‑wicking stack can be configured for heavy exudate. It is not a performance claim; always follow IFUs and local protocols.
Scenario | Example stack (illustrative only) | Notes/links |
|---|---|---|
Heavy‑exudate VLU under compression | Silicone contact layer; optional gelling fiber primary for viscous exudate; superabsorbent secondary; compression wrap | For category context, see Super Absorbent Dressings and Silicone Foam Dressings at SLK Medical. |
Additional reading (category‑level): The MASD Best Practice Statement (2025) at Wounds International and the foam fluid‑handling overview (2024) on PMC.
Applying these protocols consistently will help you prevent maceration in high‑exudate wounds while preserving compression and offloading goals. Start with the algorithm, build a stack that matches exudate burden, protect the edges, and audit outcomes over the next 2–4 weeks—then adjust based on what you observe at the bedside.
